EncephRX's Seed Round

EncephRX raised a round of funding on July 08, 2011. Investors include Maryland Technology Development Corporation.

EncephRX is developing a small molecule platform for treatment of neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's disease. This platform will provide a first-in-class ther…

Articles about EncephRX's Seed Round: